Infusion-related HSR to systemic therapy is a serious adverse effect that significantly impacts disease management, quality of life, and life expectancy. Careful assessment of patients prior to initiating systemic therapy would enable the identification of patients at higher risk for HSR.

Occupational exposure to hazardous drugs such as antineoplastic agents is associated with health risks such as those associated with reproductive health and potential increased risk of cancer.

LGBT individuals may show an increased incidence of certain cancers, but are less likely to receive regular medical care and standard cancer screenings. This lack of adequate medical care may be partially due to stigma and discrimination in health care settings.

Despite the known negative impacts of substance misuse and abuse among patients with cancer, these issues often go undiagnosed and/or untreated in patients with cancer.

Cardiovascular toxicities can be managed effectively with appropriate therapy if they are recognized early.

This information was originally presented at the NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care held in Orlando, Florida, from March 22 - 24, 2018.

This information was originally presented at the NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care held in Orlando, Florida, from March 22 - 24, 2018.

Join Laura Michaud, PharmD, BCOP, FASHP, CMQ from The University of Texas MD Anderson Cancer Center for this webinar in the 2018 NCCN Pharmacy Update Webinar Series on the topic New Agents for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting.

This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.